Sunshine Biopharma settles dispute with former Nora Pharma president for CAD$1.5M

Sunshine Biopharma Inc.

Company to pay CAD$1.5M (approx US$1.06M) to Malek Chamoun to settle all claims and cross-claims.
Settlement includes earn-out, bonuses, indemnity in lieu of notice, and expense reimbursement; no admission of liability.
Chamoun must sell all his Sunshine Biopharma shares within 30 days; non-compete and non-solicitation obligations terminated.
Mutual releases of all claims; parties agree to confidentiality and non-disparagement.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.